Alethea Capital Management’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMRX
DA
Alethea Capital Management's IMRX Position: Q3 2026 in Review
Alethea Capital Management held its Immuneering (IMRX) position steady in Q3 2026 at 472,935 shares worth $1.94M. The position accounts for 0.99% of the portfolio, ranked #5.
Alethea Capital Management first reported a position in IMRX in Q2 2025 and has held it in 6 quarters since. The position peaked at $2.36M in Q2 2026. 131 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.
- Alethea Capital Management held 472,935 shares of Immuneering worth $1.94M as of Q3 2026.
- Alethea Capital Management left its Immuneering share count unchanged in Q3 2026.
- Immuneering made up 0.99% of Alethea Capital Management's portfolio in Q3 2026, its #5 holding.
- Alethea Capital Management first reported a position in Immuneering in Q2 2025 and has held it in 6 quarters since.
- Alethea Capital Management's Immuneering position peaked at $2.36M in Q2 2026.
- 131 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.
Based on Alethea Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.